Chimeric Therapeutics (ASX:CHM) is headed for the CAR-T ‘Big Time’
Chimeric Therapeutics (ASX:CHM) We spoke to Dr Rebecca McQualter, CEO of Chimeric Therapeutics (ASX:CHM), about the…
Great Northern Minerals is playing with the big dogs in Mountain Pass, California
Great Northern Minerals (ASX:GNM) We talked to Scott Downsborough, General Manager of Great Northern Minerals (ASX:…
St George Mining (ASX:SGQ) is flying high on the wings of Rare Earths and Niobium
St George Mining (ASX:SGQ) We spoke with John Prineas, Executive Chairman of St George Mining (ASX:SGQ),…
Weebit Nano (ASX:WBT) has been gaining strong commercial momentum in 2025!
Weebit Nano (ASX:WBT) We spoke with Coby Hanoch (CEO) and Eran Briman (VP of Marketing &…
BrainChip (ASX:BRN) is taping out AKD1500 for volume production in 2026: Interview with CEO Hehir
BrainChip (ASX:BRN) We spoke to BrainChip CEO Sean Hehir about the tape-out of AKD1500 in anticipation…
Basin Energy (ASX:BSN) is on to a potentially very significant Rare Earths discovery in Queensland
Basin Energy (ASX:BSN) We spoke to Pete Moorhouse, Managing Director of Basin Energy, about the company’s…
Calmer Co (ASX: CCO) is seeing a strong growth acceleration: Interview Zane Yoshida
Calmer Co (ASX: CCO) We spoke to Zane Yoshida, CEO of the Calmer Co (ASX: CCO),…
Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with Dr. Kilian Kelly
Cynata Therapeutics (ASX:CYP) We spoke to Dr. Kilian Kelly, CEO of Cynata Therapeutics (ASX:CYP) about the…
Zeotech (ASX:ZEO): Its payday is around the corner
Zeotech (ASX:ZEO) We spoke to Zeotech CEO James Marsh about the near term payday that is…
Singular Health Group (ASX: SHG): Interview with Denning Chong and Dr. Jose Pelayo
Singular Health Group (ASX:SHG) We spoke with Denning Chong, CEO of Singular Health (ASX:SHG) and with…
Nanoveu (ASX:NVU) lets drones fly on steroids with its Edge AI chips
Nanoveu (ASX:NVU) We spoke to Mohamed Sabry, Founder and CTO of semiconductor developer EMASS, which was…
Weebit Nano FY25 results: Interview with CEO Coby Hanoch
Weebit Nano FY25 results We spoke to Coby Hanoch, CEO of Weebit Nano (ASX:WBT), about the…
Atomo Diagnostics (ASX:AT1): Commercialisation is going into higher gear
Atomo Diagnostics (ASX:AT1) We spoke to John Kelly, CEO of Atomo Diagnostics (ASX:AT1), about progress the…
Key Drivers of Tech Stocks in 2025: Marc Kennis at TechKnow Invest 2025
Key Drivers of Tech Stocks and our Current Stock Picks in the Semiconductor space Pitt Street…
Imagion Biosystems (ASX:IBX) is getting ready for a Phase 2 study: Interview with Chair Bob Proulx
Imagion Biosystems (ASX:IBX) We talked with Bob Proulx, Executive Chairman of Imagion Biosystems, about the company’s…